Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morning versus evening administration of roflumilast in asthma
2004-001065-18Phase 3Completed
- Sponsor
- Altana Pharma
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roflumilast in asthma, sponsored by Altana Pharma. Started Sep 2004; status: completed.
02
Drugs
roflumilast
03
Conditions
asthma
Beyond the preview
Go deeper on 2004-001065-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001065-18.